Moneycontrol PRO

you are here: HomeNewsBusinessCNBC-TV18 CommentsSun, Merck sign patent licensing agreement for Januvia

SHOW NAMES

Trending Topics

Sensex Live Texmaco Rail Share Price John Cockerill India Shares GK Energy IPO Opens Today iValue Infosolutions IPO Day 2

business

Sun, Merck sign patent licensing agreement for Januvia

Merck Sharp & Dhome and Sun Pharma, who have a co-marketing tie up for Merck's diabetes drug Januvia, have now included a patent licensing agreement in their arrangement in a bid to strengthen their case. Merck and Sun are fighting a patent infringement suit against Glenmark, reports CNBC TV18's Archana Shukla.

first published: Jun 27, 2013 06:33 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347